NASDAQ NMS - GLOBAL MARKET · LONA
-0.19% · -$0.0150 · Vol 9.7K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
LeonaBio Inc

LeonaBio Inc

Pharmaceuticals
$7.68
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Earnings absence reason unknown
LONA
LeonaBio Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

64/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is LONA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading LONA catalysts
About LeonaBio Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2020
Employees
19
Country
US

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$7.88
Day high
$7.99
Day low
$7.60
Previous close
$7.70
52W high
$11.68
-34.20% from high
52W low
$4.34
46% of range
Market cap
$72.4M
EPS
$-5.0600
Beta
0.55
Shares out
9.4M
Volume
9.7K
0.19× rel vol
Avg volume
51.4K
VWAP
$7.74
Price history computed in-house
1W
-0.32%
1M
+3.99%
3M
-20.53%
SMA 50 $8.12 · below
SMA 200 Not reported · Not reported
52W position 46%

LONA overview

Veridion Score
64
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around LONA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading LONA Form 4 filings
Public disclosures

Congress activity in LONA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for LONA in the cached public ledger.

Federal contracts

LONA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for LONA in this window.
Lobbying spend

LONA lobbying filings, year to date.

Registered lobbying filings matched to LeonaBio Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for LONA in this window.
Loading news for LONA
Analyst ratings
Sovereign unlock shows live analyst consensus for LONA.
Options
Sovereign unlock shows live options positioning for LONA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.